Dice Therapeutics Inc (DICE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | ||
| Net Income | -23,739 | -16,609 |
| Depreciation Amortization | 697 | 525 |
| Accounts payable and accrued liabilities | N/A | 338 |
| Other Working Capital | 1,663 | 485 |
| Other Operating Activity | 700 | 160 |
| Operating Cash Flow | $-20,679 | $-15,101 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -148 | -131 |
| Purchase Of Investment | N/A | -3,649 |
| Sale Of Investment | N/A | 21,800 |
| Other Investing Activity | 18,151 | 0 |
| Investing Cash Flow | $18,003 | $18,020 |
| Cash Flows From Financing Activities | ||
| Debt Repayment | N/A | -91 |
| Other Financing Activity | 53,895 | -330 |
| Financing Cash Flow | $53,895 | $-421 |
| Beginning Cash Position | 8,617 | 8,618 |
| End Cash Position | 59,836 | 11,116 |
| Net Cash Flow | $51,219 | $2,498 |
| Free Cash Flow | ||
| Operating Cash Flow | -20,679 | -15,101 |
| Capital Expenditure | N/A | -131 |
| Free Cash Flow | -20,679 | -15,232 |